Patent details

Basic Information

Publication number:

EP2763654

PCT Application Number:

EP2012003810

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127596526

PCT Publication Number:

WO2013037479

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

OPHTHTALMIC COMPOSITIONS COMPRISING PROSTAGLANDIN F2 ALPHA DERIVATIVES AND HYALURONIC ACID

French Title of Invention:

COMPOSITIONS OPHTALMIQUES CONTENANT DES DÉRIVÉS DE PROSTAGLANDINE 2F ALPHA ET DE L'ACIDE HYALURONIQUE

German Title of Invention:

OPHTHALMISCHE ZUSAMMENSETZUNGEN ENHALTEND PROSTAGLANDIN-F2-ALPHA-DERIVATE UND HYALURONSÄURE

SPC Number:

Dates

Filing date:

11/09/2012

Grant date:

29/04/2020

EP Publication Date:

13/08/2014

PCT Publication Date:

21/03/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/04/2020

EP B1 Publication Date:

29/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/09/2020

Expiration date:

11/09/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/04/2020

 

 

Name:

Unither Pharmaceuticals

Address:

151 rue André Durouchez CS 28028, 80084 Amiens Cedex 2, France (FR)

Inventor

Name:

HADJ-SLIMANE, Réda

Address:

France (FR)

Priority

Priority Number:

11306137

Priority Date:

12/09/2011

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/00; A61K 31/5377; A61K 31/5575; A61K 31/728; A61K 47/02; A61K 47/36; A61P 27/06;

Publication

European Patent Bulletin

Issue number:

202018

Publication date:

29/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages